TABLE 2.

Meta-analysis Results

	Number of Studies			Mean Prevalence (95% CI)
Location	Total	Pre-RV Vaccine	Post-RV Vaccine	All	Pre-RV Vaccine	Post-RV Vaccine
Overall	29	21	8	15% (13–18)	15% (12–19)	16% (12–22)
Community	8	3	5	15% (11–21)	11% (4–21)	18% (14–23)
Outpatient	7	6	1	14% (10–19)	13% (9–17)	21% (15–27)
Hospital	19	16	3	16% (12–21)	17% (12–22)	13% (4–26)

Pooled estimates of norovirus infection prevalence among AGE cases overall, per location and per rotavirus vaccine introduction.

RV indicates rotavirus.